Go to deals
Consumer & Retail | Healthcare

Camelia pharmacy chain has been acquired by Medigate Management UAB

CGP Management UAB has sold the Camelia pharmacy chain (UAB Nemuno vaistinė and subsidiaries) to Medigate Management UAB.

UAB Nemuno vaistinė, operating under the brand name Camelia, is the leading pharmacy chain in Lithuania. The group carries out retail and wholesale trade in pharmaceuticals, food supplements, medical devices and cosmetics. Camelia’s pharmacy chain includes a countrywide network of approximately 300 own and 30 franchise outlets and manages one of the leading online pharmacies in Lithuania. Besides pharmacy retail and wholesale, the group is also involved in the development of pharmaceutical and nutraceutical products under its own brand names (private label).

Medigate Management UAB is a private investment holding company owned by Mr. Petras Bartkus (a minority shareholder in Camelia before the transaction). Medigate Management owns UAB Medigate, a developer and wholesaler of food supplements, medical devices and cosmetics in Lithuania.

CGP Management UAB is a private holding company owned by the founder of the Camelia pharmacy chain.

Oaklins’ team in Lithuania acted as the sole financial advisor to CGP Management on the sale of the Camelia pharmacy chain to Medigate Management.

Service
M&A sell-side
Parties

Talk to the deal team

 Mindaugas  Matulaitis

Mindaugas Matulaitis

Associate Partner

Vilnius, Lithuania
Oaklins Baltics
 Natalja  Titova

Natalja Titova

Associate Partner

Vilnius, Lithuania
Oaklins Baltics
 Ieva Kamilė Paleckytė

Ieva Kamilė Paleckytė

Analyst

Vilnius, Lithuania
Oaklins Baltics
 Agnė  Purlytė

Agnė Purlytė

Analyst

Vilnius, Lithuania
Oaklins Baltics

Related deals

Groupe Nature acquires Winco
Consumer & Retail | Healthcare

Groupe Nature acquires Winco

Groupe Nature has signed an agreement with Nicolas Watine, founder and CEO of Winco, to acquire his stake in the comany. It specializes in the distribution of health and cosmetic products in parapharmacies affiliated to supermarket chains. This acquisition strengthens Groupe Nature’s position as a multi-channel specialist in the distribution of organic health products.

Learn more
Shield Therapeutics has raised funds
Healthcare

Shield Therapeutics has raised funds

Shield Therapeutics Plc has completed a placing, subscription and open offer. The primary use of the funds is to launch Accrufer® in the USA.

Learn more
Xeros Technology Group has closed a placing and open offer
Consumer & Retail | Industrial Machinery & Components

Xeros Technology Group has closed a placing and open offer

Xeros Technology Group Plc. has successfully raised funds to support business activities.

Learn more